AJMC® Peer Exchange® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's managed care professionals.
Immunotherapy in Nonmelanoma Skin Cancers
Jason Luke, MD, FACP leads a panel of medical experts in a discussion around immunotherapy in the field of Cutaneous Squamous Cell Carcinoma (CSCC) and Basal Cell Carcinoma (BCC).
Employing Effective Multidisciplinary Care to Reduce the Burden of Myelodysplastic Syndrome
A panel of medical experts discuss the significance of collaborative care and key considerations in the treatment of myelodysplastic syndrome (MDS).
Important Updates in the Management of Patients with Heart Failure
Medical experts discuss the prevalence of heart failure, current treatment strategies and unmet needs in heart failure management.
Opportunities for Biosimilars: A Multidisciplinary Perspective
Experts discuss the transition from biologics to biosimilars and emphasize the importance of adaptability when non-medical switching occurs.
Treatment Strategies in Hepatocellular Carcinoma (HCC): Optimizing Outcomes and Resource Allocation
Clinical pathways considerations and key treatment strategies for hepatocellular carcinoma (HCC) are discussed by a panel of medical experts.
Tailoring Treatment Selection for Various Stages of NSCLC: Optimizing Patient Outcomes
Important Updates in the Management of Patients with Metastatic Colorectal Cancer
A panel of medical experts hold a discussion surrounding updates in metastatic colorectal cancer.
Examining Novel Treatment Options for Patients with Acne Vulgaris
Hilary Baldwin, MD, Arash Mostaghimi, MD, Steven Feldman, MD, PhD, and Casey Butrus, PharmD, discuss updates in acne therapy and multidisciplinary care for patients.
Oral SERD Therapy in ER+/HER2- Metastatic Breast Cancer
A panel of experts explore a novel class of medications for patients with metastatic breast cancer, the oral selective estrogen receptor degrader (SERDs).
Managing Patients with Schizophrenia: Provider and Payer Considerations
A panel of medical experts will gather to discuss current and unmet needs in the treatment landscape of schizophrenia.
CDK 4/6 Inhibitors in High-Risk Early Breast Cancer
A panel of medical experts explore CDK 4/6 inhibitors for patients diagnosed with high-risk early breast cancer.
Optimizing HIV Treatment
A panel of experts describe the burden of the HIV epidemic including its impacts on patients and payers, review the latest evidence and treatment guidelines informing decision-making in HIV, and discuss unmet needs and future directions in the treatment of HIV.
Exploring the Potential Impact of RSV (Respiratory Syncytial Virus) Vaccines in Adult Population
A panel of medical experts discuss the significance of RSV vaccination.
Bruton Tyrosine Kinase Inhibitors in Patients with Multiple Sclerosis
Ryan Haumschild, PharmD, MS, MBA leads a panel of medical experts in a discussion surrounding the potential role of BTK inhibitors in the treatment of multiple sclerosis.
Treatment with Bispecifics in Relapsed-Refractory Multiple Myeloma
Medical experts explore the use of bispecifics in the relapsed / refractory myeloma treatment landscape.
The Evolving Treatment Landscape of Atopic Dermatitis and Other Dermatological Conditions
A panel of medical experts discuss the current treatment landscape surrounding atopic dermatitis.
Generalized Pustular Psoriasis: Provider and Payer Considerations for Care
Management of Multidrug-Resistant HIV
A panel of medical experts provide insights on the treatment landscape of Multidrug-Resistant HIV.
Emerging Therapies in Geographic Atrophy
A panel of medical experts describe the treatment landscape of Geographic Atrophy.
The Evolving Treatment Landscape and Value-Based Considerations for the Management of Wet Age-Related Macular Degeneration and Diabetic Macular Edema
Experts discuss the disease burden and treatment landscape for age-related macular degeneration (AMD), and diabetic macular edema (DME).
Utilizing Pathway-Directed Therapy in Multiple Myeloma
A panel of medical experts provide insights to the treatment landscape surrounding multiple myeloma (MM).
Bruton Tyrosine Kinase Inhibitors in Leukemia and Lymphoma
A panel of experts provide an overview of the disease burden associated with leukemia and lymphoma, discuss the current treatment landscape of BTK inhibitors, and offer payer considerations in treatment management.
Medication Management Considerations in COPD
Medical experts discuss optimal treatment strategies and current standards of care surrounding therapy for patients with COPD.
Updates in the Management of Myelodysplastic Syndromes (MDS)
A panel of experts describe the clinical burden of myelodysplastic syndromes (MDS), discuss treatment paradigms and standard of care therapies, and explore unmet needs and future directions in the treatment of MDS.
Disease Burden and Management of Vitiligo
A panel of experts explore the clinical and economic burden of vitiligo, review treatment paradigms and standard of care therapies, and discuss unmet needs and future directions for treatment of vitiligo.
Population Health Management of Chronic Kidney Disease (CKD)
An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease (CV), and the methods of treatment used on the patient populations.
A Population Health Approach to Managing Heart Failure
A panel of experts explore the updated heart failure guidelines and the impact on current treatment landscape for patients, with a focus on evidence-based medicine, payer strategies, and collaborative care management.
Managed Care Perspectives: Optimizing Women’s Reproductive Health
A panel of experts provide an overview of the burden of common health concerns in women’s reproductive years, review currently available treatment options, and discuss a personalized treatment approach for women’s reproductive health. Ryan Haumschild, PharmD, MBA, MS, discusses implications of the Affordable Care Act (ACA) to women’s reproductive health, along with methods to ensure timely access to appropriate therapy.
Treatment and Management of Interstitial Lung Disease (ILD)
A panel of expert discuss interstitial lung disease (ILD) in depth, from definition to the best possible therapy options for treatment.
Improving Access to Alternative Therapies for Treatment Resistant Depression
A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.
2 Clarke Drive Cranbury, NJ 08512